International Journal of Infectious Diseases Vol.160 (2025)
Suggested Citation
Rattanaumpawan P., Horthongkham N., Suwannakarn K., Athipanyasilp A., Jongwutiwes U. Severe dengue hemorrhagic fever after TAK-003 dengue vaccination: A case report of a potential vaccine-associated adverse reaction. International Journal of Infectious Diseases Vol.160 (2025). doi:10.1016/j.ijid.2025.108062 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/112613
Title
Severe dengue hemorrhagic fever after TAK-003 dengue vaccination: A case report of a potential vaccine-associated adverse reaction
We report a severe dengue case that developed symptoms 5 days post-TAK-003 dengue vaccine administration. Whole-genome sequencing confirmed co-detection of all four dengue serotypes with high similarity to vaccine strains, especially DENV-2. This finding warrants further investigation into a potential association with vaccine adverse events.